AI주식인사이트AI Stock Insight
C

하이퍼코퍼레이션

065650KOSDAQ기계장비 및 관련 물품 도매업

45.3 / 100

Reference Date: 2026-07-24

Financial Score7.0 / 40
News Sentiment21.3 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Slightly up 4.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hyper Corporation operates three main business divisions: Commerce, Biopharma, and Tech. The Commerce division sells PC peripherals and household products, while the Biopharma division develops innovative drugs, including anti-inflammatory treatments, Alzheimer's therapies, and a non-opioid painkiller (MDR-652). The company is expanding its market through new ventures like the early dementia diagnostic kit QPLEX Alz Plus and the EcoVacs brand, driving revenue growth.

Number of Employees

83people

Average Salary

33.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 8.654.0Point
PBR
1.46Industry Average 0.580.0Point

2.5x industry avg (risky)

ROE
-4.61Industry Average 2.780.0Point

Well below industry avg

Debt Ratio
39.24Industry Average 6.760.0Point

5.8x industry avg (risky)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲21.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼159.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -103.0% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 2,040Won52-week high 4,78052-week low 1,654
1-month return4.0Point

1m +4.08% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-07-23
  • Neutral주요사항보고서(타법인주식및출자증권양수결정)2026-07-16
  • Neutral주요사항보고서(자기전환사채매도결정)2026-07-16
  • Neutral[기재정정]주주총회소집결의2026-07-01
  • Neutral금전대여결정2026-06-30